Improved positive predictive value of non-invasive prenatal testing through integration with second-trimester ultrasound soft markers for fetal chromosomal abnormalities: a retrospective cohort study - Report - MDSpire

Improved positive predictive value of non-invasive prenatal testing through integration with second-trimester ultrasound soft markers for fetal chromosomal abnormalities: a retrospective cohort study

  • By

  • Dan Fu

  • Qian Wu

  • Yun Ju

  • Min Jiang

  • Suhua Zhang

  • May 29, 2026

  • 0 min

Share

Clinical Report: Enhancing Positive Predictive Value of Non-Invasive Prenatal Testing

Overview

Integrating second-trimester ultrasound soft markers with non-invasive prenatal testing (NIPT) significantly improves the positive predictive value (PPV) for detecting fetal chromosomal abnormalities. This study found that a combined strategy increased PPV to 83.3% while maintaining high specificity.

Background

Non-invasive prenatal testing (NIPT) has transformed prenatal screening by providing high sensitivity for common fetal aneuploidies. However, the variability in positive predictive value (PPV) poses challenges, particularly due to the potential for false-positive results leading to unnecessary invasive procedures. Understanding how to refine risk assessment using ultrasound markers is crucial.

Data Highlights

MetricValue
Confirmed Chromosomal Abnormalities24 (7.9%)
NIPT Sensitivity100%
NIPT PPV55.8%
Improved PPV with Combined Strategy83.3%
Specificity of Combined Strategy98.9%

Key Findings

  • NIPT achieved 100% sensitivity but only 55.8% PPV in the study cohort.
  • 63.2% of false-positive cases showed no soft markers.
  • The combined strategy improved PPV to 83.3% with 98.9% specificity.
  • Women aged <35 years benefited the most from the combined approach.
  • Strategy (a) achieved 100% sensitivity for trisomies 18 and 13 but only 62.5% for trisomy 21.

Clinical Implications

The integration of second-trimester ultrasound soft markers with NIPT can enhance risk stratification for fetal chromosomal abnormalities.

Conclusion

Combining second-trimester ultrasound findings with NIPT results can enhance the PPV for detecting fetal chromosomal abnormalities.

Related Resources & Content

  1. Frontiers | Improved Positive Predictive Value of Non-Invasive Prenatal Testing Through Integration with Second-Trimester Ultrasound Soft Markers for Fetal Chromosomal Abnormalities: A Retrospective Cohort Study
  2. Screening for Fetal Chromosomal Abnormalities | ACOG
  3. Clinical Rheumatology — Impact of Pre-Analytical Factors on Risk Evaluation in First Trimester Combined Screening for Patients with Systemic Lupus Erythematosus
  4. Journal of Medical Internet Research (JMIR) — Adaptive Fast-Slow Large Language Model Framework for Multidimensional Classification of Prenatal Ultrasound Reports: Comparative Study
  5. Frontiers in Endocrinology — Factors associated with de novo aneuploidy across different preimplantation genetic testing cycles: a retrospective cohort study
  6. Pediatric Cardiology — Inequities in Prenatal Detection of Critical Congenital Heart Disease Persist, Highlighting Racial/Ethnic and Socioeconomic Gaps Alongside Technical Challenges
  7. Screening for Fetal Chromosomal Abnormalities | ACOG
  8. NIPT Predictive Value Calculator
  9. Frontiers | Improved Positive Predictive Value of Non-Invasive Prenatal Testing Through Integration with Second-Trimester Ultrasound Soft Markers for Fetal Chromosomal Abnormalities: A Retrospective Cohort Study

Original Source(s)

Related Content